Search results for: MIGRAINE
New NICE recommended migraine pill to help 170k patients
Migraine affects a total of 4.5 million people in the UKÂ Â
Patients suffering from chronic and episodic migraine attacks are set to benefit from a...
Acute migraine? NICE recommends Pfizer’s rimegepant as potential option
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for treating acute...
Pfizer to pay Biohaven $11.6 bln to tap migraine market
Pfizer said on Tuesday it will pay $11.6 billion to buy Biohaven Pharmaceuticals, making a big bet on its ability to boost sales of...
NICE recommends Erenumab to prevent migraine
The National Institute for Health and Care Excellence (NICE) has recommended monoclonal antibody erenumab for preventing migraine in its final draft guidance.
Erenumab is being...
Teva launches pre-filled fremanezumab pen for anti-CGRP migraine therapy Â
Teva UK has launched a pre-filled pen for fremanezumab (Ajovy) injection.
This will give patients on Ajovy added convenience and flexibility not previously available with the pre-filled...
NICE recommends new ‘cost-effective’ migraine drug
National Institute for Health and Care Excellence (NICE) today recommended Teva’s migraine drug fremanezumab, sold under the brand name Ajovy, for NHS use.
The final...